---
title: ConsortiEX Blog | DSCSA (2)
description: DSCSA |  (2)
---

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png "ConsortiEX")](https://www.consortiex.com)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

# ConsortiEX Blog

- [ConsortiEX](https://info.consortiex.com/blog/tag/consortiex)
- [DSCSA](https://info.consortiex.com/blog/tag/dscsa)
- [DQSA](https://info.consortiex.com/blog/tag/dqsa)
- [FDA](https://info.consortiex.com/blog/tag/fda)
- [Compounding](https://info.consortiex.com/blog/tag/compounding)
- [batch compounding](https://info.consortiex.com/blog/tag/batch-compounding)
- [drug quality and security act](https://info.consortiex.com/blog/tag/drug-quality-and-security-act)

[![DSCSA Compliance as a Service: T3 Verification](https://info.consortiex.com/hs-fs/hubfs/Untitled-8.jpg?width=788&name=Untitled-8.jpg)](https://info.consortiex.com/blog/dscsa-compliance-service-t3-verification)

January 16, 2019

## [DSCSA Compliance as a Service: T3 Verification](https://info.consortiex.com/blog/dscsa-compliance-service-t3-verification)

ConsortiEX is proud to announce T3 verification, the newest feature to be added to our DSCSA Compliance as a Service (CaaS) module. The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy.

[Read More](https://info.consortiex.com/blog/dscsa-compliance-service-t3-verification)

[![In Recent Guidance, FDA aims for Patient Safety at 503B Facilities](https://info.consortiex.com/hs-fs/hubfs/Untitled-10.jpg?width=788&name=Untitled-10.jpg)](https://info.consortiex.com/blog/fda-guidance-503b)

December 17, 2018

## [In Recent Guidance, FDA aims for Patient Safety at 503B Facilities](https://info.consortiex.com/blog/fda-guidance-503b)

The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)

[Read More](https://info.consortiex.com/blog/fda-guidance-503b)

[![FDA Issues Guidance on Verification Systems](https://info.consortiex.com/hs-fs/hubfs/fdalogo.png?width=788&name=fdalogo.png)](https://info.consortiex.com/blog/fda-guidance-verification-system)

December 13, 2018

## [FDA Issues Guidance on Verification Systems](https://info.consortiex.com/blog/fda-guidance-verification-system)

The FDA recently issued a draft guidance regarding verification\* systems in accordance with the Drug Supply Chain Security Act (DSCSA).

[Read More](https://info.consortiex.com/blog/fda-guidance-verification-system)

[![ConsortiEX ASHP Midyear Recap, Prioritizing Patient Safety](https://info.consortiex.com/hs-fs/hubfs/integration.jpg?width=788&name=integration.jpg)](https://info.consortiex.com/blog/consortiex-ashp18-midyear-recap)

December 6, 2018

## [ConsortiEX ASHP Midyear Recap, Prioritizing Patient Safety](https://info.consortiex.com/blog/consortiex-ashp18-midyear-recap)

We want to thank everybody who came to visit our booth at this year’s ASHP Midyear Clinical Meeting & Exhibition. We always appreciate the opportunity to show off our products to the people who need them most.

[Read More](https://info.consortiex.com/blog/consortiex-ashp18-midyear-recap)

[![Be Compliant with Confidence, DSCSA Compliance as a Service](https://info.consortiex.com/hs-fs/hubfs/Facilitate-coompliance-2-1.jpg?width=788&name=Facilitate-coompliance-2-1.jpg)](https://info.consortiex.com/blog/ashp18-dscsa)

December 3, 2018

## [Be Compliant with Confidence, DSCSA Compliance as a Service](https://info.consortiex.com/blog/ashp18-dscsa)

Understanding the rules and regulations behind DSCSA Compliance can be a daunting task. As deadlines pass, the FDA regularly updates what it means to be compliant. ConsortiEX is proud to offer DSCSA Compliance as a Service (CaaS). Our CaaS module removes the burden of being compliant from the dispenser community with\[...\]

[Read More](https://info.consortiex.com/blog/ashp18-dscsa)

[![Come see what You've been Missing, ConsortiEX is Attending ASHP Midyear](https://info.consortiex.com/hs-fs/hubfs/1500-users.jpg?width=788&name=1500-users.jpg)](https://info.consortiex.com/blog/ashp-2018)

December 1, 2018

## [Come see what You've been Missing, ConsortiEX is Attending ASHP Midyear](https://info.consortiex.com/blog/ashp-2018)

ConsortiEX is proudly attending ASHP Midyear. Stop by Booth 900 to see how our intuitive Pharmacy-Focused ERP solutions can enhance your patient safety, ensure quality control, and simplify compliance, first-hand and in-person. Our new InsightRX Passive Audit Monitoring hood will be on display.

[Read More](https://info.consortiex.com/blog/ashp-2018)

[![Recent FDA Guidance Sparks Concerns from Industry Leaders](https://info.consortiex.com/hs-fs/hubfs/fdalogo-1.png?width=788&name=fdalogo-1.png)](https://info.consortiex.com/blog/industry-leaders-voice-recent-fda-draft-guidance)

November 27, 2018

## [Recent FDA Guidance Sparks Concerns from Industry Leaders](https://info.consortiex.com/blog/industry-leaders-voice-recent-fda-draft-guidance)

Several key industry players have issued responses to the FDA in regard to the recent draft guidance on the use of Product Identifiers, and the policy on grandfathered product, in compliance with the Drug Supply Chain Security Act (DSCSA).

[Read More](https://info.consortiex.com/blog/industry-leaders-voice-recent-fda-draft-guidance)

[![FDA Releases Final Guidance on Upcoming Product Identifier Requirements](https://info.consortiex.com/hs-fs/hubfs/fdalogo-2.png?width=788&name=fdalogo-2.png)](https://info.consortiex.com/blog/fda-dscsa-guidance-product-identifier-requirements)

November 23, 2018

## [FDA Releases Final Guidance on Upcoming Product Identifier Requirements](https://info.consortiex.com/blog/fda-dscsa-guidance-product-identifier-requirements)

On Sep. 9, 2018, the FDA released a Final Guidance regarding the use of product identifiers on packages and homogenous cases of product as mentioned in the Drug Supply Chain Security Act (DSCSA).

[Read More](https://info.consortiex.com/blog/fda-dscsa-guidance-product-identifier-requirements)

[![FDA Commissioner Details Steps to Ensure the Quality of and Preserve Access to Compounded Drugs](https://info.consortiex.com/hs-fs/hubfs/fdalogo-3.png?width=788&name=fdalogo-3.png)](https://info.consortiex.com/blog/fda-commissioner-statement)

September 11, 2018

## [FDA Commissioner Details Steps to Ensure the Quality of and Preserve Access to Compounded Drugs](https://info.consortiex.com/blog/fda-commissioner-statement)

The practice of compounding medicines can provide important public health opportunities. The FDA’s compounding program – including implementation of the compounding provisions of the law – is a priority for the agency. We recognize that in delivering on implementation commitments, we must balance the need to preserve\[...\]

[Read More](https://info.consortiex.com/blog/fda-commissioner-statement)

[![Thanks for stopping by the ConsortiEX booth to discover the power of our Pharmacy-Focused ERP.](https://info.consortiex.com/hs-fs/hubfs/Rx-focus-ERP-2.jpg?width=788&name=Rx-focus-ERP-2.jpg)](https://info.consortiex.com/blog/thanks-for-stopping-by-the-consortiex-booth-to-discover-the-power-of-our-pharmacy-focused-erp-2)

June 7, 2018

## [Thanks for stopping by the ConsortiEX booth to discover the power of our Pharmacy-Focused ERP.](https://info.consortiex.com/blog/thanks-for-stopping-by-the-consortiex-booth-to-discover-the-power-of-our-pharmacy-focused-erp-2)

We want to thank everybody who came to visit our booth at this year’s ASHP Summer Meetings & Exhibition.

[Read More](https://info.consortiex.com/blog/thanks-for-stopping-by-the-consortiex-booth-to-discover-the-power-of-our-pharmacy-focused-erp-2)

[1](https://info.consortiex.com/blog/tag/dscsa/page/1) [2](https://info.consortiex.com/blog/tag/dscsa/page/2) [3](https://info.consortiex.com/blog/tag/dscsa/page/3)

### Recent Posts

- [In Response to the FDA Announcement](https://info.consortiex.com/blog/in-response-to-the-fda)   
  October 11, 2024
- [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights)   
  August 6, 2024
- [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership)   
  March 13, 2024

### Topics

- [ConsortiEX (22)](https://info.consortiex.com/blog/tag/consortiex)
- [DSCSA (21)](https://info.consortiex.com/blog/tag/dscsa)
- [DQSA (18)](https://info.consortiex.com/blog/tag/dqsa)
- [FDA (18)](https://info.consortiex.com/blog/tag/fda)
- [Compounding (17)](https://info.consortiex.com/blog/tag/compounding)
- [batch compounding (16)](https://info.consortiex.com/blog/tag/batch-compounding)
- [drug quality and security act (16)](https://info.consortiex.com/blog/tag/drug-quality-and-security-act)
- [patient safety (16)](https://info.consortiex.com/blog/tag/patient-safety)
- [assure-trak (15)](https://info.consortiex.com/blog/tag/assure-trak)
- [Blog (14)](https://info.consortiex.com/blog/tag/blog)
- [Track and Trace (13)](https://info.consortiex.com/blog/tag/track-and-trace)
- [Drug Supply Chain Security Act (12)](https://info.consortiex.com/blog/tag/drug-supply-chain-security-act)
- [IV workflow software (12)](https://info.consortiex.com/blog/tag/iv-workflow-software)
- [Industry (12)](https://info.consortiex.com/blog/tag/industry)
- [Pharmacy IT software (11)](https://info.consortiex.com/blog/tag/pharmacy-it-software)
- [health care pharmacy (11)](https://info.consortiex.com/blog/tag/health-care-pharmacy)
- [iv workflow (11)](https://info.consortiex.com/blog/tag/iv-workflow)
- [503B (10)](https://info.consortiex.com/blog/tag/503b)
- [503A (9)](https://info.consortiex.com/blog/tag/503a)
- [compliance (9)](https://info.consortiex.com/blog/tag/compliance)
- [iv workflow management (9)](https://info.consortiex.com/blog/tag/iv-workflow-management)
- [Total Ingredient Life Cycle (8)](https://info.consortiex.com/blog/tag/total-ingredient-life-cycle)
- [enterprise resource planning (8)](https://info.consortiex.com/blog/tag/enterprise-resource-planning)
- [pedigree to patient (8)](https://info.consortiex.com/blog/tag/pedigree-to-patient)
- [pharmacy software (8)](https://info.consortiex.com/blog/tag/pharmacy-software)
- [traceability (8)](https://info.consortiex.com/blog/tag/traceability)
- [USP (7)](https://info.consortiex.com/blog/tag/usp)
- [anticipatory compounding (7)](https://info.consortiex.com/blog/tag/anticipatory-compounding)
- [assure-track (6)](https://info.consortiex.com/blog/tag/assure-track)
- [pharmaceutical compounding (6)](https://info.consortiex.com/blog/tag/pharmaceutical-compounding)
- [Spotlight (5)](https://info.consortiex.com/blog/tag/spotlight)
- [compounded sterile preparations (5)](https://info.consortiex.com/blog/tag/compounded-sterile-preparations)
- [compounded sterile productions (5)](https://info.consortiex.com/blog/tag/compounded-sterile-productions)
- [pharmacy (5)](https://info.consortiex.com/blog/tag/pharmacy)
- [pharmacy it (5)](https://info.consortiex.com/blog/tag/pharmacy-it)
- [quality assurance (5)](https://info.consortiex.com/blog/tag/quality-assurance)
- [DSCSA Compliance (4)](https://info.consortiex.com/blog/tag/dscsa-compliance)
- [EDI (4)](https://info.consortiex.com/blog/tag/edi)
- [News (4)](https://info.consortiex.com/blog/tag/news)
- [T3 Documentation (4)](https://info.consortiex.com/blog/tag/t3-documentation)
- [USP 797 (4)](https://info.consortiex.com/blog/tag/usp-797)
- [clean room (4)](https://info.consortiex.com/blog/tag/clean-room)
- [compounded IV bags (4)](https://info.consortiex.com/blog/tag/compounded-iv-bags)
- [compounded syringe (4)](https://info.consortiex.com/blog/tag/compounded-syringe)
- [drug serialization (4)](https://info.consortiex.com/blog/tag/drug-serialization)
- [order management (4)](https://info.consortiex.com/blog/tag/order-management)
- [sterile product compounding (4)](https://info.consortiex.com/blog/tag/sterile-product-compounding)
- [transaction history transaction information transa (4)](https://info.consortiex.com/blog/tag/transaction-history-transaction-information-transa)
- [DQSA - USP 797 (3)](https://info.consortiex.com/blog/tag/dqsa-usp-797)
- [DSCSA CaaS (3)](https://info.consortiex.com/blog/tag/dscsa-caas)
- [DSCSA Software (3)](https://info.consortiex.com/blog/tag/dscsa-software)
- [Drug Counterfeiting (3)](https://info.consortiex.com/blog/tag/drug-counterfeiting)
- [EPCIS (3)](https://info.consortiex.com/blog/tag/epcis)
- [Requirements (3)](https://info.consortiex.com/blog/tag/requirements)
- [drug borrow loan (3)](https://info.consortiex.com/blog/tag/drug-borrow-loan)
- [dscsa compliance as a service 3T (3)](https://info.consortiex.com/blog/tag/dscsa-compliance-as-a-service-3t)
- [exchange (3)](https://info.consortiex.com/blog/tag/exchange)
- [guidance (3)](https://info.consortiex.com/blog/tag/guidance)
- [illegitimate product (3)](https://info.consortiex.com/blog/tag/illegitimate-product)
- [pharmacy erp (3)](https://info.consortiex.com/blog/tag/pharmacy-erp)
- [suspect product (3)](https://info.consortiex.com/blog/tag/suspect-product)
- [3Ts (2)](https://info.consortiex.com/blog/tag/3ts)
- [ASHP (2)](https://info.consortiex.com/blog/tag/ashp)
- [COVID-19 (2)](https://info.consortiex.com/blog/tag/covid-19)
- [Compliance as a Service (2)](https://info.consortiex.com/blog/tag/compliance-as-a-service)
- [Compounding Pharmacy (2)](https://info.consortiex.com/blog/tag/compounding-pharmacy)
- [DSCSA service (2)](https://info.consortiex.com/blog/tag/dscsa-service)
- [DSCSA software and service (2)](https://info.consortiex.com/blog/tag/dscsa-software-and-service)
- [Data Entry (2)](https://info.consortiex.com/blog/tag/data-entry)
- [Drug supply chain transparency (2)](https://info.consortiex.com/blog/tag/drug-supply-chain-transparency)
- [Electronic Data Interchange (2)](https://info.consortiex.com/blog/tag/electronic-data-interchange)
- [Environmental monitoring (2)](https://info.consortiex.com/blog/tag/environmental-monitoring)
- [Manual T3 Conversion (2)](https://info.consortiex.com/blog/tag/manual-t3-conversion)
- [NDC tracking (2)](https://info.consortiex.com/blog/tag/ndc-tracking)
- [Passive auditing (2)](https://info.consortiex.com/blog/tag/passive-auditing)
- [Prescription tracking (2)](https://info.consortiex.com/blog/tag/prescription-tracking)
- [T3 (2)](https://info.consortiex.com/blog/tag/t3)
- [T3 Conversion (2)](https://info.consortiex.com/blog/tag/t3-conversion)
- [T3s (2)](https://info.consortiex.com/blog/tag/t3s)
- [compounded IV bag (2)](https://info.consortiex.com/blog/tag/compounded-iv-bag)
- [compounded syringes (2)](https://info.consortiex.com/blog/tag/compounded-syringes)
- [drug supply chain (2)](https://info.consortiex.com/blog/tag/drug-supply-chain)
- [drug transfers (2)](https://info.consortiex.com/blog/tag/drug-transfers)
- [dscsa deadline (2)](https://info.consortiex.com/blog/tag/dscsa-deadline)
- [fda guidance (2)](https://info.consortiex.com/blog/tag/fda-guidance)
- [patient specific compounding (2)](https://info.consortiex.com/blog/tag/patient-specific-compounding)
- [pharmacy serialization (2)](https://info.consortiex.com/blog/tag/pharmacy-serialization)
- [pharmacy supply chain (2)](https://info.consortiex.com/blog/tag/pharmacy-supply-chain)
- [product (2)](https://info.consortiex.com/blog/tag/product)
- [product identifier (2)](https://info.consortiex.com/blog/tag/product-identifier)
- [quarantine (2)](https://info.consortiex.com/blog/tag/quarantine)
- [regulation (2)](https://info.consortiex.com/blog/tag/regulation)
- [serialization (2)](https://info.consortiex.com/blog/tag/serialization)
- [sterile injectable compound (2)](https://info.consortiex.com/blog/tag/sterile-injectable-compound)
- [vaccine (2)](https://info.consortiex.com/blog/tag/vaccine)
- [503B. outsourcing facility (1)](https://info.consortiex.com/blog/tag/503b-outsourcing-facility)
- [Bar Code Medication Verification (1)](https://info.consortiex.com/blog/tag/bar-code-medication-verification)
- [Central Sterile Compounding (1)](https://info.consortiex.com/blog/tag/central-sterile-compounding)
- [Cleanroom (1)](https://info.consortiex.com/blog/tag/cleanroom)
- [Compounding Quality Act (1)](https://info.consortiex.com/blog/tag/compounding-quality-act)
- [ISMP (1)](https://info.consortiex.com/blog/tag/ismp)
- [Pharmacy Informatics (1)](https://info.consortiex.com/blog/tag/pharmacy-informatics)
- [Technology Assisted IV Workflow Software (1)](https://info.consortiex.com/blog/tag/technology-assisted-iv-workflow-software)
- [USP . USP 800 (1)](https://info.consortiex.com/blog/tag/usp-usp-800)
- [audit (1)](https://info.consortiex.com/blog/tag/audit)
- [barcode (1)](https://info.consortiex.com/blog/tag/barcode)
- [central-fill (1)](https://info.consortiex.com/blog/tag/central-fill)
- [community involvement (1)](https://info.consortiex.com/blog/tag/community-involvement)
- [compounding management system (1)](https://info.consortiex.com/blog/tag/compounding-management-system)
- [deadline (1)](https://info.consortiex.com/blog/tag/deadline)
- [draft guidance (1)](https://info.consortiex.com/blog/tag/draft-guidance)
- [drug loan borrow (1)](https://info.consortiex.com/blog/tag/drug-loan-borrow)
- [drug waste (1)](https://info.consortiex.com/blog/tag/drug-waste)
- [dynamic patient specific (1)](https://info.consortiex.com/blog/tag/dynamic-patient-specific)
- [grandfathered (1)](https://info.consortiex.com/blog/tag/grandfathered)
- [grandfathered product (1)](https://info.consortiex.com/blog/tag/grandfathered-product)
- [software (1)](https://info.consortiex.com/blog/tag/software)
- [specialty compounding (1)](https://info.consortiex.com/blog/tag/specialty-compounding)
- [verification systems (1)](https://info.consortiex.com/blog/tag/verification-systems)

See all

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)](http://acc-dev.consortiex.com/)

- <https://twitter.com/ConsortiEX>
- <https://www.linkedin.com/company/10680398/>

*733 N Van Buren St, Ste 501*  
*Milwaukee, WI 53202*

*Office: (414) 231-4575*   
*Support: (888) 434-1442*

*Email: info@consortiex.com*

- [Homepage](https://www.consortiex.com/)
- [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
- [Blog](https://info.consortiex.com/blog)
- [Contact Us](https://www.consortiex.com/contact-us/)
- [DSCSA Compliance](https://www.consortiex.com/dscsa-compliance/)
- [Health System](https://www.consortiex.com/health-system/)
- [Magnifier™ Analytics](https://consortiex.com/consortiex-magnifier-analytics/)
- [Outsourcing Facility 503B](https://www.consortiex.com/outsourcing-facility-503b/)
- [Resources](https://info.consortiex.com/resources)

 2025 | ConsortiEX Inc. | All Rights Reserved